Smell Loss
Clinical Trial
Condition: Hyposmia
A Randomized, Double-Blinded, Placebo-Controlled Trial to Determine The Safety and Efficacy of CYR-064
The purpose of this study is to determine the safety and effectiveness of CYR-064 in a randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR064.
The study will take approximately 32 weeks which will include a 4-week screening period to evaluate if participants are right for the Study, followed by a 24-week Treatment Period, and a 1 week follow up after participants have completed the Study. About 150 subjects will participate in this study in about 25 research sites in the United States.
ACTIVELY ENROLLING SMELL LOSS TRIAL
Smell Loss Study Location: Colorado Springs, CO
Colorado ENT and Allergy
Smell Loss Study Location: Bethlehem, PA
Specialty Physician Associates